Determination of HER2 Gene Status and Chromosome 17 Polysomy in Penile Carcinoma and Association With HER2 Protein Levels

被引：0
|
作者：
Silva, A. M. T. [1 ]
Cunha, I. W. [1 ]
Ayala, F. [1 ]
Guimaraes, G. C. [1 ]
Lopes, A. [1 ]
Soares, F. A. [1 ]
机构：
[1] ACCamargo Hosp, Fundacao Antonio Prudente, Sao Paulo, Brazil
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)71148-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
475
引用
收藏
页码：S114 / S115
页数：2
相关论文
共 50 条
  • [21] HER2, chromosome 17 polysomy and DNA ploidy status in breast cancer; a translational study
    Altuna Halilovic
    Dagmar I. Verweij
    Annet Simons
    Marian J. P. L. Stevens-Kroef
    Susan Vermeulen
    Janet Elsink
    Bastiaan B. J. Tops
    Irene Otte-Höller
    Jeroen A. W. M. van der Laak
    Carlijn van de Water
    Oliver B. A. Boelens
    Margrethe S. Schlooz-Vries
    Jeroen R. Dijkstra
    Iris D. Nagtegaal
    Jolien Tol
    Patricia H. J. van Cleef
    Paul N. Span
    Peter Bult
    Scientific Reports, 9
  • [22] HER2 Gene Protein Assay Is Useful to Determine HER2 Status of Breast Carcinoma with HER2 IHC and FISH Double Equivocal Results
    Li, Zaibo
    Hou, Yanjun
    Nitta, Hiroaki
    MODERN PATHOLOGY, 2016, 29 : 54A - 54A
  • [23] HER2 Gene Protein Assay Is Useful to Determine HER2 Status of Breast Carcinoma with HER2 IHC and FISH Double Equivocal Results
    Li, Zaibo
    Hou, Yanjun
    Nitta, Hiroaki
    LABORATORY INVESTIGATION, 2016, 96 : 54A - 54A
  • [24] Evaluating HER2 status using HER2 Gene Protein Assay in Endometrial Cancer
    Shafi, Saba
    Parwani, Anil
    Li, Zaibo
    Nitta, Hiro
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 824 - 825
  • [25] HER2 Amplification Status in Breast Cancer: The Effect of Adjusting for "Polysomy 17"
    Gagne, I.
    Craddock, K. J.
    Mulligan, A. M.
    LABORATORY INVESTIGATION, 2013, 93 : 40A - 41A
  • [26] Evaluating HER2 status using HER2 Gene Protein Assay in Endometrial Cancer
    Shafi, Saba
    Parwani, Anil
    Li, Zaibo
    Nitta, Hiro
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 824 - 825
  • [27] HER2 Amplification Status in Breast Cancer: The Effect of Adjusting for "Polysomy 17"
    Gagne, I.
    Craddock, K. J.
    Mulligan, A. M.
    MODERN PATHOLOGY, 2013, 26 : 40A - 41A
  • [28] Intratumoral heterogeneity of HER2 protein and amplification of HER2 gene in salivary duct carcinoma
    Kondo, Yusuke
    Kikuchi, Tomoki
    Esteban, Joaquim Carreras
    Kumaki, Nobue
    Ogura, Go
    Inomoto, Chie
    Hirabayashi, Kenichi
    Kajiwara, Hiroshi
    Sakai, Akihiro
    Sugimoto, Ryousuke
    Otsuru, Mitsunobu
    Okami, Kenji
    Tsukinoki, Keiichi
    Nakamura, Naoya
    PATHOLOGY INTERNATIONAL, 2014, 64 (09) : 453 - 459
  • [29] HER2, chromosome 17 polysomy and DNA ploidy status in breast cancer; a preclinical and clinical study
    Halilovic, A.
    Verweij, D.
    Simons, A.
    Otte-Holler, I.
    van der Laak, J.
    van de Water, C.
    Dijkstra, J.
    van Cleef, P.
    Nagtegaal, I.
    Span, P.
    Bult, P.
    VIRCHOWS ARCHIV, 2017, 471 : S51 - S51
  • [30] Polysomy 17 as Predictor of HER2 Gene Overexpression in Breast Cancer Patients
    Al-Abdulwahed, O.
    McMahill, B.
    Zou, Y.
    Saleki, R.
    CYTOGENETIC AND GENOME RESEARCH, 2012, 136 (04) : 351 - 351
12345